M&A announcement
Logotype for Enovis Corporation

Enovis (ENOV) M&A announcement summary

Event summary combining transcript, slides, and related documents.

Logotype for Enovis Corporation

M&A announcement summary

1 Sep, 2026

Deal rationale and strategic fit

  • Acquisition accelerates entry into surgical robotics, expanding the enabling technology ecosystem and reinforcing a long-term growth strategy in orthopedics and automation.

  • eCential complements existing platforms, providing planning, navigation, and robotic capabilities for surgeons across care settings, and integrates with ASTRA Portal and ARVIS.

  • Establishes a Robotics Center of Excellence in Grenoble, France, leveraging a specialized team and local talent pool.

  • Builds on a pre-existing partnership, validating technical and cultural alignment and a shared innovation roadmap.

  • Focus is on knee and shoulder applications, leveraging validated technology and proprietary robotic control layers.

Financial terms and conditions

  • Upfront enterprise value of €155 million (~€176 million cash at closing), plus up to €35 million in milestone payments tied to regulatory and commercial deliverables.

  • Funded through cash on hand and existing revolving credit facility; leverage increases by about half a turn, expected to return to ~3x by end of 2027.

  • No revenue contribution expected until 2028; margin dilution of ~150 basis points in 2027, offset by 50 basis points of underlying improvement.

  • Free cash flow conversion expected to reach 50% in 2027 and 70% in 2029, with at least $100 million in free cash flow targeted for next year.

Synergies and expected cost savings

  • Integration enables a unified, scalable tech infrastructure and cohesive surgeon experience across platforms.

  • Commercial teams will benefit from selling and servicing a single technology platform, improving efficiency.

  • Acquisition supplements engineering with robotics expertise, supporting the creation of a Robotics Center of Excellence.

  • Accelerates time to market for robotic solutions and enhances development capabilities.

  • Integration expected to dilute adjusted EBITDA margin by 150 basis points in 2027, partially offset by 50 basis points of underlying improvement.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more